1. Introduction {#s0005}
===============

The animal pole of the amphibian egg is heavily pigmented; the pigment is eumelanin ([@b0170], [@b0030]) and is synthesized by the enzyme tyrosinase (EC 1.14.18.1; monophenol, dihydroxyphenylalanine: oxygen oxidoreductase) from [l]{.smallcaps}-tyrosine ([@b0085], [@b0095], [@b0120], [@b0115], [@b0140]). The occurence of melanin at the animal pole of the amphibian egg, where the cell nucleus is located, may be related to photoprotection ([@b0010], [@b0115]). The amphibian egg has been also considered as a pigment cell ([@b0010]); the occurrence of melanin at the animal pole has been also related, to the warming of the egg and embryo by absorption of solar radiation ([@b0010], [@b0160]).

We have previously investigated the expression of tyrosinase activity during *Bufo bufo* development, by using biochemical techniques ([@b0090]). A very feeble tyrosinase activity has been found by polyacrylamide disc gel electrophoresis during development, from the first cleavage till muscular response stages, but none by spectrophotometer in the extracts of melanosomes until developmental stage 19 ([@b0090]). During *Rana pipiens* development the tyrosinase enzymatic activity gradually increase from the neural plate stage till stage 19 (heart beat) ([@b0015], [@b0035], [@b0040]).

The aim of this work is to detect when during *Bufo bufo* development the embryo tyrosinase gene is transcriptionally expressed and thus eumelanin other than that of maternal origin, can be produced. In order to address this question we prepared *B. bufo* tyrosinase specific primers to detect by Real-time quantitative PCR (qRT-PCR) the expression of tyrosinase mRNA during *B. bufo* development. It is of some interest to investigate if tyrosinase, an oxygen using enzyme, is expressed when oxygen is transported to the tissues. During amphibian development cytochrome oxidase and respiration highly increases from the tail bud stage ([@b0020], [@b0050]); thus we have also investigated if some relationship exists between tyrosinase activity and oxygen consumption during *B. bufo* development ([@b0105]).

2. Materials and methods {#s0010}
========================

2.1. *Bufo bufo* embryo collection {#s0015}
----------------------------------

The eggs of *B. bufo* were collected along the banks of the lake Pietranzoni 900 m s.l.m. near L'Aquila Abruzzo (Italy). The eggs were kept at 12--14 °C in tap water. Jelly was removed from early embryonic stages by treatment with 0.5% sodium thioglycolate at pH 8.6 in a ratio of 1:1 (v/v). The embryos were staged by reference to [@b0150]. At the selected developmental stages (stage 7, sixth cleavage; stage 12, late gastrula; stage 17, tail bud; stage 18, muscular response; stage 20, gill circulation; stage 22, tail fin circulation; stage 25, operculum complete) 160 embryos at different development stages were used to isolate and purify melanosomes in order to measure tyrosinase activity; 50 embryos at the different developmental stages were used for RNA purification.

2.2. Melanosome preparation {#s0020}
---------------------------

Melanosomes were purified from *B. bufo* embryo homogenates at various stages of development, at 12--14 **°**C. Homogenates (2 ml), diluted with 0.10 M potassium phosphate buffer, pH 7.0, in a 1:1 (v:v) ratio, were layered on a discontinuous sucrose density gradient (1.8 M sucrose, 2 ml, and 1.4 M sucrose, 1 ml) and centrifuged for 60 min at 100,000*g*. The pellets were resuspended in 2 ml of the same buffer and centrifuged as above. The final pellets consisted mainly of melanosomes. Protein concentration was determined by the biuret method, using bovine serum albumin as a standard.

2.3. Tyrosinase assay and polyacrylamide gel electrophoresis {#s0025}
------------------------------------------------------------

Tyrosinase activity was spectrophotometrically measured by using the dopachrome assay procedure with [l]{.smallcaps}-3,4-dihydroxyphenylalanine ([l]{.smallcaps}-DOPA) as substrate. 5 mM [l]{.smallcaps}-DOPA in sodium phosphate buffer (0.1 M pH 6.8) and melanosome extract, in a total volume of 1.0 ml were incubated at 25 °C; the dopachrome formation was monitored continuously by measuring the absorbance increase at 475 nm ([@b0080]).

To determine the active form of tyrosinase, 15 μg of protein from the melanosome extract was loaded onto 8% (w/v) polyacrylamide gel ([@b0075]). Running buffer and gels contained 0.1% sodium dodecyl sulfate (SDS), but the samples were not heated and mercaptoethanol was omitted from the loading buffer. After electrophoresis, the gels were stained for catecholase activity with 5.0 mM [l]{.smallcaps}-DOPA in 0.1 M phosphate buffer pH 6.8 for 120 min. Electrophoresis was performed at 4 °C, at a constant current of 25 mA. Controls with a tyrosinase inhibitor, 1.0 × 10^−4^ M phenylthiourea (PTU), were done. The protein bands were shown by 0.1% Coomassie brilliant G250 blue staining.

2.4. Determination of melanin content {#s0030}
-------------------------------------

50 *B. bufo* embryos at different development stages were suspended in 0,1 mM sodium phosphate buffer, pH 6.8, at 1:5 ratio (w/v) and were sonicated 5 times on ice (20 s/8 cycles/50% power), with Bandelin, Sonopuls D2070 sonicator (Berlin, Germany). Then, Brij 35 was added to the suspension at a final concentration of 0.1%; samples were homogenized with a Potter--Elvehjem homogenizer, motor driven for 10 cycles of 2 min at intervals of 15 s, and protein content was determined. Melanin content was determined as reported ([@b0145]) with minor modifications. NaOH (4 N), containing 10% dimethyl sulfoxide, was added to the samples in the ratio 1:1, and these were homogenized for 10 cycles of 2 min at intervals of 30 s. The samples were incubated at 70 °C for 120 min, shaken vigorously every 10 min and centrifuged for 5 min at 10,000*g*. The melanin content of the supernatant was spectrophotometrically determined as the absorbance at 405 nm. The obtained values were normalized to the total protein concentration.

2.5. RNA extraction, purification and cDNA synthesis {#s0035}
----------------------------------------------------

Total RNA was isolated from different embryonic stages (50 pooled individuals). RNase-free mortars and pestles were used in combination with liquid nitrogen to disrupt frozen tissue samples into a powder with the RNAqueous^TM^ (Ambion Huntingdon, Cambridgeshire, UK) kit as described by the manufacturer and treated with DNAse (Roche Diagnostic GmbH, Penzberg, Germany). Then, the RNA was treated with Recombinant RNase-free DNAse I from bovine pancreas (Roche Diagnostics, Indianapolis, USA) according to the manufacturer's instructions. The purity of all RNA samples was assessed at absorbance ratios of A260/A280 and A260/A230 using a Nanodrop 2000 spectrophotometer (Thermo Scientific, Waltham, WA) and the integrity of the RNA was immediately checked using 1.2% agarose gel electrophoresis (1.3 μg samples). RNA concentration was calculated based on absorbance values at 260 nm, and RNA samples were stored at −80 °C until use. RNA was used as a template for reverse transcriptase (RT); cDNA was generated from 1 μg of total RNA by Superscript III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen by Life Technologies, Carlsbad, CA, USA), according to the manufacturer's instruction. The 2 × RT Reaction Mix includes oligo(dT)20, random hexamers, MgCl~2~, and deoxynucleotides (dNTPs) in a buffer formulation that has been optimized for qRT-PCR. *Escherichia coli* RNase H was used in the kit to remove the RNA template from the cDNA:RNA hybrid molecules after first-strand synthesis. Absence of DNA was checked by comparing cDNA samples with RNA samples which were not reverse transcribed (minus RT control). The obtained cDNAs were used for polymerase chain reaction (PCR) and qRT-PCR.

2.6. PCR, cloning and sequencing {#s0040}
--------------------------------

Partially degenerate PCR primers (FORREVBB) were designed from conserved regions of tyrosinase genes: *Rana nigromaculata* (GenBank accession number [D12514](ncbi-n:D12514){#ir090})*, Xenopus laevis* (GenBank accession number [BC043815](ncbi-n:BC043815){#ir095})*, Rana galamensis* (GenBank accession number [AY341749.1](ncbi-n:AY341749.1){#ir100}), *Bufo japonicus* (GenBank accession number [AB612059](ncbi-n:AB612059){#ir105}) *Leptodactylus fuscus* (GenBank accession number [AY341760.1](ncbi-n:AY341760.1){#ir110})*, Rana temporaria* (GenBank accession number [AF249182.1](ncbi-n:AF249182.1){#ir115}). PCR was performed using 1 μL of cDNA as template (500 ng). PCR conditions were: 10 ×buffer (New England Biolabs), 0.6 mM dNTPs, 0.4 mM primers (each) and 1.25 U Taq DNA polymerase (New England Biolabs) in a 50 μL reaction mix. After amplification, fragments of the expected size were gel-extracted using S.N.A.P. UV-Free Gel Purification Kit (Invitrogen-Life science) and cloned using the TOPO TA kit (Invitrogen-life technologies) according to the manufacturers' directions. The found active site sequence coding for tyrosinase were used for the synthesis of the specific primers (BFGSP1, BFGSP2, BRGSP1, BRGSP2) as shown in [Table 1](#t0005){ref-type="table"}. The specific primers were used with the kit "3′ RACE and 5′ RACE System for Rapid Amplification of cDNA Ends", in accordance with the instructions (Invitrogen-life technologies). Then the specific primers (EXPRFOR, EXPRREV), shown in [Table 1](#t0005){ref-type="table"}, were used to detect *B. bufo* tyrosinase mRNA expression at the different developmental stages. The amplification products were resolved by 1.5% agarose gel electrophoresis in Tris acetate-EDTA (TAE) buffer (running conditions: 90 V for 90 min) and stained with ethidium bromide. Band sizes were checked by using the Invitrogen Trackit 100 bp DNA ladder.Table 1Primers used in this study. Primer sequences, accession numbers, amplicon sizes and PCR efficiencies are indicated.Gene nameAccession numberPrimer namePrimer sequence 5′--3′; Tm (°C).Product (bp)(%)PCR efficiency**Primer sequences used to clone and amplify tyrosinase mRNA *Bufo bufo***Degenerate PCR primers conserved regions of tyrosinase genes CuA[D12514](ncbi-n:D12514){#ir020}; [BC043815](ncbi-n:BC043815){#ir025};\
[AY341749.1](ncbi-n:AY341749.1){#ir030}; [AB612059](ncbi-n:AB612059){#ir035};\
[AY341760.1](ncbi-n:AY341760.1){#ir040}; [AF249182.1](ncbi-n:AF249182.1){#ir045}FORREVBBF: 5′-GGNAACTTYATGGGNTAYAAYTG-3′\
R: 5′-TGCAGCCANACRAASAGRTCRTA-3′268Regions of tyrosinase genes CuA[FM864217.1](ncbi-n:FM864217.1){#ir050}BFGSP1F: 5′-CAAGTTCATCGCCTACCTCAAT-3′ (60.1)BFGSP2F: 5′-AAACGCACCATsCAGCCCAGAC-3′ (62.4)BRGSP1R: 5′-GTCTGGGCTGATGGTGCGTTT-3′ (62.6)BRGSP2R: 5′-ATTGAGGTAGGCGATGAACTTG-3′ (60.0)Tyrosinase[FM864217.1](ncbi-n:FM864217.1){#ir055}EXPRF: 5′-CACCATGAGAGGTAGTATCATGATA-3′ (62.9)\
R: 5′-TCATAGATTGGACTGGTAAGTGCT-3′ (62.6)1510NADH dehydrogenase subunit I[JQ348484.1](ncbi-n:JQ348484.1){#ir060}EXNADHF:5′ GCCTCAAATTCCAAGTACGC 3′ (59.7)\
R: 5′ GGTGGAGGATCCCAAGAAAA 3′ (59.8)378  **qRT-PCR assay sequences of primers**16S rRNA[AY555020.1](ncbi-n:AY555020.1){#ir065}BB16SF: 5′-CCAATACACTTGAACAACGAACCA-3′ (59.3) R: 5′-GAGACCCTGATCCAACATCGA-3′ (59.8)11098.44Histone H4[AY675291.1](ncbi-n:AY675291.1){#ir070}BOFORH4F: 5′-GCATCACCAAGCCTGCCAT-3′ (58.8)\
R: 5′-GAAGACTTTCAGCACCCCG-3′ (58.8)10198.87NADH dehydrogenase subunit I[JQ348484.1](ncbi-n:JQ348484.1){#ir075}BOFORNADHF: 5′-AGCCCTCTCAAGCCTCACTGT-3′ (61.8)\
R: 5′-CGTATGAAATCGTCTGCGCTACT-3′(60.6)10996.79Tyrosinase[FM864217.1](ncbi-n:FM864217.1){#ir080}TYR1F: 5′-CCATGGACCGCAATGCTAAC-3′ (59.4)\
R: 5′-GTGCAGGGAATTGTGCATGT-3′ (57.3)11098.74Tyrosinase[FM864217.1](ncbi-n:FM864217.1){#ir085}*TYR2*F: 5′-GCCACTGGGACCTACGAACA-3′ (61.4)\
R: 5′-CGCATCCCTGGAGGAGTAATAG-3′ (62.1)10899.29IL1-alphapAW109 control RNA (Applied Biosystems\_)DM151F: 5′\--GTCTCTGAATCAGAAATCCTTCTATC-3′ (54.9)\
R: 5′-CATGTCAAATTTCACTGCTTCATCC-3′ (57.2)30898.70[^1]

2.7. Quantitative Real-Time PCR {#s0045}
-------------------------------

In this study, after a detailed search in the literature, three housekeeping genes were selected (16S rRNA, Histone H4, NADH dehydrogenase subunit I), these genes are among the most common ones frequently used, as reference genes, for normalization of qRT-PCR. Two couples of primers were prepared on the base of *B. bufo* tyrosinase sequence. To facilitate the qRT-PCR analysis of all the investigated genes under the same reaction conditions, primers were designed using Primer Express 3.0 software (PE Applied Biosystems, USA) under default parameters. The PCR primer sequences used to quantitate the expression of all the genes are shown in [Table 1](#t0005){ref-type="table"}. All the RNA samples were tested for genomic DNA contamination by qRT-PCR negative controls of cDNA samples omitting reverse transcriptase. In all of the negative control samples no amplification of the fluorescent signal was detected, thus proving that the extraction procedure, including the DNAse treatment, effectively removed genomic DNA from all of the RNA samples.

As an exogenous control, 106 copies of pAW101 RNA (GeneAmp Gold RNA PCR Control Kit by Life Technologies Carlsbad, CA, USA)/μg of RNA extracted were added to each sample. The two control primers (DM151, DM152) included in this kit amplified a 308 bp product. Real-time PCR was performed using an Applied Biosystems 7300 Real-Time PCR System and software (Applied Biosystems, Foster City, USA). qRT-PCR was performed with the SYBR GreenER™ qPCR SuperMix for ABI PRISM, which is a ready-to-use cocktail containing all components (including ROX Reference Dye at a final concentration of 500 nM), except primers and template. The PCR Mastermix contained the primers (1 μL primer pair mix of 10 μM primer pair stock), 25 μL of 2*x* GreenER™ qPCR SuperMix for ABI PRISM (Applied Biosystems), 1 μL of diluted cDNA (corresponding to 1 ng) and sterile nuclease free water to a final volume of 50 μL. All the PCRs were performed under following conditions: 2 min at 50 °C, 10 min at 95 °C, and 40 cycles of 15 s at 95 °C and 60 s annealing and extension at 60 °C in 96-well optical reaction plates (Applied Biosystems, USA). The specificity of the qRT-PCR reactions was monitored by the melting curve analysis (60--95 °C), after 40 cycles, using SDS software (version 1.4, Applied Biosystems) shown in [Fig. 1](#f0005){ref-type="fig"}. Three biological replicates for each sample were used for Real-time PCR analysis and three technical replicates were analyzed for each biological replicate; a single peak was observed and this confirms the synthesis of a single product.Figure 1Specificity of qRT-PCR amplification. (A) Melting curves of the 3 reference genes, tyrosinase and (6) pAW109 control SYBR-Green qRT-PCR shows a single peak. (B) Agarose gel (2.5%) electrophoresis showing amplification of a specific qRT-PCR product of the expected size, (1) 16S rRNA, (2) histone H4, (3) NADH dehydrogenase subunit I, (4) tyrosinase 1, (5) tyrosinase 2 and pAW109 control. DNA ladder (M).

2.8. Standard curve construction and Real-time PCR {#s0050}
--------------------------------------------------

To ensure the reliability of the amplification results, the qRT-PCR amplification efficiencies were determined by the standard curve and melting curve analyses. Standard curves were constructed by using serially diluted cDNA as a template prior to the candidate gene expression analysis. Each template used in the qRT-PCR amplification was analyzed by three independent runs. PCR efficiencies and regression coefficients were calculated by the QGene software (Version 4.3.10). For all the primers, a single peak was observed, thus confirming the synthesis of a single product that was further validated, as shown in [Fig. 1](#f0005){ref-type="fig"}, by analysis of the qRT-PCR product on a 2.5% agarose gel. Gene expression analyses were conducted by an Applied Biosystems 7300 Real-Time PCR System using the SYBR GREEN method as indicated above.

2.9. Expression stability analysis of candidate reference genes {#s0055}
---------------------------------------------------------------

We used the RefFinder tool (<http://fulxie.0fees.us/?type=reference>) for the assessment and screening of the reference genes (16S rRNA, Histone H4, NADH dehydrogenase subunit I). The RefFinder tool integrates the currently available major computational programs (geNorm, Normfinder, BestKeeper and the Comparative CT method, ([@b0110], [@b0005], [@b0175], [@b0155]) to compare and rank the tested candidate reference genes (data not shown).

2.10. Data analysis and statistics {#s0060}
----------------------------------

Statistical analysis was performed by unpaired Student's *t*-test or One-Way ANOVA test (PAST Paleontological Statistics software Version 3.0) ([@b0045]). Data analysis was carried out using the ABI 7300 SDS System software version 1.4 (Applied Biosystems). Gene Expression Macro™ Version 1.1. All the biological replicates were used to calculate the average Ct value. Phylogenetic trees were constructed by the maximum likelihood method, using the Molecular Evolutionary Genetics Analysis (MEGA 7.0) software, ([@b0130], [@b0070]).

3. Results {#s0065}
==========

3.1. Nucleotide sequence and primary protein sequence {#s0070}
-----------------------------------------------------

The nucleotide sequence FM864217 of *B. bufo* tyrosinase cDNA is long 1593 bp and the deduced primary protein sequence B6VPX8, as expected, is long 531 aminoacids as shown in [Fig. 2](#f0010){ref-type="fig"}. The gray bars indicate the sequences of tyrosinase cDNA coding for CuA and CuB copper binding sites and the deduced polypeptide primary structures. As presented in [Fig. 3](#f0015){ref-type="fig"} the CuA and CuB copper binding sites of *B. bufo* tyrosinase are highly conserved throughout the phylogenetic scale, from Amphibia to Homo, but in reality from bacteria to man ([@b0115]). In these regions, which are also found in plant tyrosinases, six conserved histidine residues, that are symmetrically arranged, are believed to form a binuclear copper center and are crucial for the copper-binding and/or enzymatic activity ([@b0055], [@b0065]). There are 14 cysteine residues at conserved positions distributed unevenly in the sequences as shown in [Fig. 3](#f0015){ref-type="fig"}. From [Fig. 3](#f0015){ref-type="fig"} it might erroneously be deduced that, due to the high homology of *B. bufo* tyrosinase active site aminoacid sequence to those of *Pelophylax nigromaculatus* and *Xenopus tropicalis* the tyrosinases of these species are closely related to the *B. bufo* one ([@b0180]). On the contrary, no close relationship is found when comparing the base sequence coding for *B. bufo* tyrosinase to those of *Pelophylax nigromaculatus* and other different anurans as shown in [Fig. 4](#f0020){ref-type="fig"}: the closest tyrosinase coding sequences are those of Bufonidae, as expected. The phylogenetic tree shown is in congruence with previously published phylogenetic trees ([@b0125], [@b0135]).Figure 2Bufo bufo tyrosinase cDNA and deduced aminoacid sequences (GenBank accession n. FM864217; B6VPX8. (□) signal peptide; (![](fx2.gif)) EGF-like domain; (![](fx3.gif)) laminin-type EGF-like domain; CuA and CuB copper binding sites are evidenced by gray bars and dark bars. Putative signal peptide (underlined) was predicted using SignalP 4.1 Server (<http://www.cbs.dtu.dk/services/SignalP/>), ([@b0100]). Searches for EGF-like domain and laminin-type EGF-like domain were conducted at PROSITE (<http://prosite.expasy.org/scanprosite/>) ([@b0025]). Functional analysis of protein by classifying them into families and predicting domains and important sites were performed using InterPro ([@b0060]); protein sequence analysis & classification (<https://www.ebi.ac.uk/interpro/search/sequence-search>) ([@b0060]).Figure 3Alignment of deduced amino acid sequences of vertebrate tyrosinases. Deduced amino acid sequences from cDNA clones of *Bufo bufo* B6VPX8 are aligned with previously identified sequences of human (*Homo sapiens* P14679), mouse (*Mus musculus* P11344), quail (*Coturnix coturnix japonica* Q08410), chicken (*Gallus gallus* P55024), turtle (*Pelodiscus sinensis* K7GG37), frog (*Pelophylax nigromaculatus* Q04604), amphibia (*Xenopus tropicalis* F7CL37, *Pelophylax nigromaculatus* Q04604), actinopterygii (*Danio rerio* Q6DGE4) and medaka fish (*Oryzias latipes* P55025) tyrosinases. Tyrosinases sequences were aligned using the CLUSTAL W2 program. The two copper binding sites of tyrosinase (CuA and CuB) are boxed and conserved histidine residues are indicated in red. Conserved cysteine residues in red (∗). Putative signal peptide cleavage site ►. Four conserved putative *N*-glycosylation sites are underlined in red. Gaps introduced to maximize sequence homology are represented by dashes. Asterisks indicate identical amino acids.Figure 4Evolutionary relationships of anura taxa tyrosinase genes. Nucleotide accession numbers for the sequences used to construct this dendrogram are given close to the species name. The evolutionary history was inferred using the Neighbor-Joining method ([@b0130]). The optimal tree with the sum of branch length = 1.49899421 is shown. The evolutionary distances were computed using the Maximum Composite Likelihood method ([@b0165]) and are in the units of the number of base substitutions per site. The analysis involved 52 nucleotide sequences. All positions containing gaps and missing data were eliminated. There were a total of 313 positions in the final dataset. Evolutionary analyses were conducted in MEGA7 ([@b0070]).

3.2. Tyrosinase levels in the developmental stages of Bufo bufo {#s0075}
---------------------------------------------------------------

*B. bufo* developmental stages 7, 12, 17, 18, 20, 22 and 25 were investigated for tyrosinase mRNA levels by RT-PCR and qRT-PCR.

Two different couples of specific primers, prepared from the *B. bufo* tyrosinase cDNA sequence were used to amplify by qRT-PCR tyrosinase cDNA and thus to detect the *B. bufo* developmental stage at which the gene is expressed. As shown in [Fig. 5](#f0025){ref-type="fig"}A, during *B. bufo* development tyrosinase mRNA is expressed at the developmental stage 17--18 and the maximal expression occurs at stage 20 in accord with tyrosinase activity ([l]{.smallcaps}-DOPA oxidase), that significantly increases from stage 18 to stage 25 as shown in [Fig. 6](#f0030){ref-type="fig"}A and B. As expected tyrosinase gene and activity expression curves are parallel to the oxygen consumption of *B. bufo* embryo, when an increase of tyrosinase gene and activity expression and oxygen consumption occur, i.e. after the developmental stages 17--19 when blood circulation starts as shown in [Fig. 6](#f0030){ref-type="fig"}B and C. As mitochondrial respiratory chain generates reactive oxygen species (ROS), as well as melanogenesis, it is interesting that the tyrosinase promoter of the anuran *Rana nigromaculata* has two ROS responsive elements (GenBank: [D37779.1](ncbi-n:D37779.1){#ir125}). As shown in [Fig. 7](#f0035){ref-type="fig"}, the expression analysis conducted with the RT-PCR technique essentially confirms the data of the qRT-PCR by the intensity of the electrophoretic band of 1510 bp of the tyrosinase sequence. The levels of melanin seem initially to decrease and then to stabilize in the course of development as shown in [Fig. 4](#f0020){ref-type="fig"}B. During *Rana pipiens* development tyrosinase mRNA is accumulated at stage 13 (neural plate) ([@b0035], [@b0040]).Figure 5qRT-PCR expression level of tyrosinase gene and melanin pigment content at the different developmental stages of *Bufo bufo*. (A) Expression levels of TYR mRNA at different developmental stages of *Bufo bufo* measured by qRT-PCR. (B) About 50 embryos at the different developmental stage were dissolved in lysis buffer; the melanin pigment content was spectrophotometrically determined at 405 nm and the obtained values were normalized to the total protein concentration. Data represent mean ± SEM of triplicate assays. ^\*^Significant differences (*P* \< 0.05) are indicated by asterisks.Figure 6Tyrosinase activity. (A) Native SDS electrophoretic evidence of the catecholase activity at different *Bufo bufo* developmental stages. 15 μg protein of melanosome extract was loaded onto polyacrylamide gel and the gels were stained with [l]{.smallcaps}-DOPA + PTU, [l]{.smallcaps}-DOPA and Coomassie brilliant G250 blue. (B) The tyrosinase activity was measured spectrophotometrically, by using as substrate 5 mM [l]{.smallcaps}-DOPA dissolved in 100 mM sodium phosphate buffer pH 6.8, at 25 °C (by recording dopachrome production at 475 nm). (C) Curve of O~2~ consumption during *Bufo bufo* development ([@b0105]). Data represent mean ± SEM of triplicate assays.Figure 7Quantification of *Bufo bufo* tyrosinase mRNA by RT-PCR and 1.5% agarose gel electrophoresis. Tyrosinase mRNA expression was determined by RT-PCR of total mRNA obtained from different developmental stages of *Bufo bufo*. NADH dehydrogenase subunit I expression (378 bp) was used as an internal housekeeping mRNA. M: markers (Invitrogen's 100 bp DNA Ladder); lane 1--8 stage 25; lane 2--9 stage 22; lane 3--10 stage 20; lane 4--11 stages 18; lane 5--12 stage 17; lane 6--13 stage 12; lane 7--14 stage 7. Quantification of tyrosinase and NADH dehydrogenase subunit I was accomplished densitometrically measuring the ethidium bromide binding intensity of the UV-irradiated PCR products by a Nanodrop 2000 spectrophotometer (Thermo Scientific, Waltham, WA). The housekeeping gene NADH dehydrogenase subunit I was used for normalization. Data represent mean ± SEM (*n* 3). ^\*^Significant differences (*P* \< 0.05) are indicated.

4. Discussion {#s0080}
=============

The tyrosinase mRNA expression profile during *B. bufo* development is in full agreement with the enzymatic activity expression as detected by biochemical methods ([@b0090]).

The expression of tyrosinase mRNA at the developmental stages 17--18 is clearly evident as well the [l]{.smallcaps}-DOPA oxidase activity of tyrosinase as shown in [Fig. 5](#f0025){ref-type="fig"}A and B, while neither enzyme activity nor mRNA expression were found before those developmental stages, contrary to *R. pipiens* development ([@b0035], [@b0040]). According to our findings during *B. bufo* development, [l]{.smallcaps}-DOPA oxidase activity at very low levels appears at stage 17 (tail bud stage) and at stage 18 (muscular response) both tyrosinase [l]{.smallcaps}-DOPA oxidase activity and mRNA expressions occur overtly. These findings while confirming the expression of tyrosinase gene after late gastrula (developmental stage 12) show a difference between *B. bufo* and *R. pipiens* developments, as in *R. pipiens* tyrosinase mRNA was found starting from the neural plate stage, by hybridization of tyrosinase cDNA to total embryo RNA and [l]{.smallcaps}-DOPA oxidase activity at developmental stage 20 (hatching) ([@b0035], [@b0040]). The different stages of tyrosinase mRNA (17--18) and [l]{.smallcaps}-DOPA oxidase activity (17--18) expressions during *B. bufo* development, compared to *R. pipiens,* respectively at stages 13 and 20 may be ascribed to the different techniques used to detect mRNA expression, PCR versus cDNA/RNA hybridization, and [l]{.smallcaps}-DOPA oxidase activity assay of the enzyme extracted from melanosomes versus ammonium sulfate protein fractions of total embryo homogenates. However, the different developmental conditions of *B. bufo* and *R. pipiens*, such as environmental temperature and exposition to solar radiation that may affect melanin pigmentation ([@b0010]) should also be taken into account.

5. Conclusion {#s0085}
=============

As a final conclusion we have here demonstrated that *B. bufo* embryo melanin is of maternal origin, at least until developmental stage 17, when first a detectable [l]{.smallcaps}-DOPA oxidase activity and embryo tyrosinase gene transcription are evident. This work shows that during *B. bufo* development tyrosinase gene and activity expressions occur starting from the developmental stage 17; differently in *R. pipiens* the tyrosinase gene expression occurs at the developmental stage 13 and the enzymatic activity at stage 20. As tyrosinase is an oxidase, we have investigated if the curves of enzymatic activity and O~2~ consumption during *B. bufo* development are correlated. The tyrosinase expression curve is parallel to that of O~2~ consumption. As previous authors report ([@b0020]) in all amphibian species tested the increase of cytochrome c oxidase and then of oxygen consumption occurs at the stage when motility begins (stage 18 muscular response). As tyrosinase in an oxidase, it appears logical that when embryo respiration increases, due to O~2~ transport in the embryo tissues, also the oxidation of tyrosinase substrates should increase and contribute to the embryo O~2~ consumption increase.

Appendix A. Supplementary data {#s0095}
==============================

Supplementary Figure 1Is a user-friend web-based comprehensive tool developed for evaluating and screening reference genes from extensive experimental datasets. It integrates the currently available major computational programs (geNorm, Normfinder, BestKeeper, and the Comparative Ct method) to compare and rank the tested candidate reference genes. Based on the rankings from each program, it assigns an appropriate weight to an individual gene and calculate the geometric mean of their weights for the overall final ranking.
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Supplementary data associated with this article can be found, in the online version, at [http://dx.doi.org/10.1016/j.sjbs.2016.10.018](10.1016/j.sjbs.2016.10.018){#ir130}.

[^1]: Accession numbers are given for each gene used in this study: GenBank, NCBI (National Center for Biotechnology). Sequences of qRT-PCR primers were designed using the Primer Express®Software version 3.0 (Applied Biosystems), F and R refer to forward and reverse primers, respectively.
